Journal of Viral Hepatitis

A health economic model to assess the cost-effectiveness of PEG IFN α-2a and ribavirin in patients with mild chronic hepatitis C
pp. 523-536(14)
Authors: Gerkens, S.; Nechelput, M.; Annemans, L.; Peraux, B.; Mouchart, M.; Beguin, C.; Horsmans, Y.

Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection
pp. 537-548(12)
Authors: Pham, T. N. Q.; Mulrooney-Cousins, P. M.; Mercer, S. E.; MacParland, S. A.; Inglot, M.; Zalewska, M.; Simon, K.; Michalak, T. I.

Increased liver mast cell recruitment in patients with chronic C virus-related hepatitis and histologically documented steatosis
pp. 549-555(7)
Authors: Franceschini, B.; Russo, C.; Dioguardi, N.; Grizzi, F.

Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications
pp. 556-563(8)
Authors: Pradat, P.; Tillmann, H. L.; Sauleda, S.; Braconier, J.-H.; Saracco, G.; Thursz, M.; Goldin, R.; Winkler, R.; Alberti, A.; Esteban, J.-I.; Hadziyannis, S.; Rizzetto, M.; Thomas, H.; Manns, M. P.; Trepo, C.

Staphylococcus aureus bacteremia in patients receiving pegylated interferon-alpha and ribavirin for chronic hepatitis C virus infection
pp. 564-569(6)
Authors: Webster, D.; Ahmed, R.; Tandon, P.; Chui, L.; McDonald, R. R.; Obarianyk, A.; Antonishyn, N.; Doucette, K.

The burden of hepatitis C in England
pp. 570-576(7)
Authors: Sweeting, M. J.; De Angelis, D.; Brant, L. J.; Harris, H. E.; Mann, A. G.; Ramsay, M. E.

Serum adiponectin in chronic hepatitis C and B
pp. 577-583(7)
Authors: Siagris, D.; Vafiadis, G.; Michalaki, M.; Lekkou, A.; Starakis, I.; Makri, M.; Margaritis, V.; Christofidou, M.; Tsamandas, A. C.; Labropoulou-Karatza, C.

Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
pp. 584-591(8)
Authors: Judd, A.; Hickman, M.; Hope, V. D.; Sutton, A. J.; Stimson, G. V.; Ramsay, M. E.; Gill, O. N.; Parry, J. V.

Cellular and humoral immune response to a third generation hepatitis B vaccine
pp. 592-598(7)
Authors: Schumann, A.; Fiedler, M.; Dahmen, U.; Grosse-Wilde, H.; Roggendorf, M.; Lindemann, M.